"This collaboration reflects our shared vision of transforming healthcare delivery globally," said Suresh Venkatachari, Chairman of QuantumNexis. "By combining Healthcare Triangle and its subsidiary QuantumNexis' innovation and execution capabilities with the robust Better platform, we are uniquely positioned to bring cutting-edge digital health solutions to emerging markets and make a meaningful impact on patient care." Partnership positions Healthcare Triangle as preferred service provider across high-gro ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) ("Hydreight" or the "Company"), a leader in U.S. nationwide digital healthcare solutions, is pleased to announce that, further to the news release of the Company dated January 15, 2026, it has closed its previously announced "bought deal" private placement with Canaccord Genuity Corp. ( ...

Key Takeaways Hims & Hers is scaling its digital platform with new specialties and integrated lab diagnostics.HIMS' platform learns from patient data to offer proactive, personalized treatment pathways.AI, data infrastructure and in-house manufacturing bolster Hims & Hers' ability to deliver care at scale.The renowned health and wellness platform, Hims & Hers Health, Inc. (HIMS) , operates at the intersection of healthcare and proprietary technology by positioning its digital platform as the core engine of ...

Core Insights - Digital healthcare platforms are expanding in consumer wellness and precision medicine, with Hims & Hers Health, Inc. (HIMS) focusing on consumer-first services and Tempus AI, Inc. (TEM) leveraging AI for precision medicine [1][2] Company Overview - HIMS operates a subscription-based platform providing personalized treatments through telehealth and pharmacy services, while TEM utilizes AI on clinical and molecular data for healthcare providers [1][2] - HIMS is expanding into lab testing and diagnostics, enhancing its service offerings in weight management, hormone health, and preventive care [6][7] - TEM is building a multimodal dataset for diagnostics and clinical decision-making, enhancing its value to healthcare providers and researchers [10][12] Stock Performance & Valuation - HIMS has underperformed with a 40.4% decline over the past three months, while TEM has decreased by 24.9% [3] - HIMS is trading at a forward price-to-sales (P/S) ratio of 2.35X, in line with the Medical sector average, whereas TEM's P/S ratio is 7.35X, above the sector average [4] Growth Drivers for Hims & Hers - HIMS is broadening its portfolio, which is expected to increase its addressable market and customer engagement [7] - The company's vertically integrated, data-driven care model enhances personalized treatment plans and quality control [8] - Global expansion and strategic capital deployment are expected to sustain long-term growth and recurring revenue [9] Growth Drivers for Tempus AI - TEM's data advantage from genomic testing and clinical data collection supports its diagnostic offerings and licensing business [10] - Increased adoption of TEM's diagnostic tools reflects integration into clinical workflows, bolstered by regulatory clearances [11] - AI-driven product expansion positions TEM as a technology partner, enhancing its long-term growth narrative [12] Earnings Projections - The Zacks Consensus Estimate for HIMS suggests a 16.8% improvement in EPS for 2026 compared to 2025 [15] - The Zacks Consensus Estimate for TEM indicates a 71.6% improvement in loss per share for 2026 compared to 2025 [18] Price Targets - Analysts project an average price target of $43.85 for HIMS, indicating a potential increase of 51.8% from the last close [20] - For TEM, the average price target is $87.92, suggesting a 34.6% increase from the last close [21] Investment Perspective - HIMS is viewed as a more favorable investment due to its consumer-focused model and expanding service offerings, despite being rated as a Zacks Rank 4 (Sell) [22] - TEM, also rated as Zacks Rank 4, has a compelling long-term growth narrative but trades at a higher valuation, indicating less margin for error [25][26]

VANCOUVER, British Columbia--(BUSINESS WIRE)--WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (the "Company†or "WELL†), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce the release of a letter to shareholders from its Founder, Chairman and Chief Executive Officer, Hamed Shahbazi, outlining the Company's strategic priorities for 2026 and the principles guidin ...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) (“Hydreight” or the “Company”), a leader in U.S. nationwide digital healthcare solutions, announced that it has entered into an agreement with Canaccord Genuity Corp. (the “Lead Underwriter”) as lead underwriter and sole bookrunner, and a syndicate of underwriters to be formed (collectively with th ...

Core Insights - Verizon Communications Inc. is increasingly focusing on the healthcare industry by delivering advanced connectivity, secure digital platforms, and intelligent technologies that enhance patient care and improve operational efficiency [1] - The company aims to extend quality healthcare services to remote areas where traditional access is limited [1] Digital Healthcare Solutions - Verizon's high-speed 5G and private network connectivity, secure cloud and edge computing platforms, and advanced cybersecurity services strengthen digital healthcare systems [2] - These services enable telemedicine, remote patient monitoring, real-time data sharing, and more efficient healthcare operations [2] Security Enhancements - The company has enhanced its healthcare security by adding new tools like the Security Management Program–Healthcare (SMP-H) and Partner Security Program (PSP) to improve compliance and protect patient data [3] - Verizon has improved its telehealth services through the BlueJeans telehealth platform by adding features like a Command Center dashboard and patient image capture [3] Strategic Partnerships - Verizon has partnered with several healthcare organizations, including AdventHealth, Tampa General Hospital, and Cleveland Clinic, to advance digital health solutions [4] - The company has also teamed up with Emory Healthcare, where its 5G technology powers a healthcare innovation lab to develop remote care [4] Innovation Centers - Verizon operates a Connected Healthcare Center to showcase real-world solutions such as virtual wards, wearable-enabled emergency services, team collaboration platforms, and virtual group consultations for patient care [5] - These initiatives enable Verizon to expand into the digital healthcare industry while creating opportunities for long-term growth and revenues [5] Competitive Landscape - Verizon faces competition from AT&T and T-Mobile in the digital health market [6][7] - AT&T is expanding its presence in digital health by using its 5G network and partnering with companies like Sovato for virtual care and remote patient monitoring [6] - T-Mobile is collaborating with CitrusBits to use 5G for connected healthcare and advanced medical training [7] Financial Performance - Verizon has gained 1.9% over the past year, while the industry has declined by 3.6% [8] - The company's shares currently trade at a price/earnings ratio of 8.09, lower than the industry average of 11.17 [11] - Earnings estimates for 2025 have declined by 0.4% to $4.68 per share, and for 2026, they have dropped by 1.4% to $4.81 over the past 60 days [12]

Hinge Health (NYSE:HNGE) is one of the most promising mid-cap healthcare stocks under $50. On December 19, the consensus ratings indicate a strong bullish stance towards Hinge Health (NYSE:HNGE). All 12 analysts covering the stock have assigned Buy ratings, which reflect favorably upon its prospects. The resulting consensus 1-year average price target for the stock is $67.53, which offers a lucrative 42.9% upside from the current level. Romaset/Shutterstock.com On December 12, Citizens reiterated its b ...

Core Viewpoint - Equasens, a leader in digital healthcare solutions, has announced its financial calendar for the 2026 financial year, detailing key dates for revenue and results announcements [1]. Group 1: Financial Calendar - 2025 annual revenue will be reported on February 5, 2026, after market close [2] - 2025 annual results will be released on March 30, 2026, before market opens [2] - 2026 Q1 revenue is scheduled for April 29, 2026, after market close [2] - The Annual General Meeting will take place on June 25, 2026 [2] - 2026 Half-year revenue will be announced on July 30, 2026, after market close [2] - 2026 Half-year results will be available on September 28, 2026, before market opens [2] - 2026 Q3 revenue will be reported on October 29, 2026, after market close [2] Group 2: Company Overview - Equasens Group has been established for over 35 years and currently employs more than 1,400 people across Europe [3] - The Group specializes in digital healthcare solutions that support healthcare professionals in their daily operations, including electronic equipment, digital solutions, and healthcare robotics [4] - Equasens is recognized for its interoperability solutions that enhance coordination among healthcare professionals, improving patient care and the efficiency of the healthcare system [5]

Core Insights - WELL Health Technologies Corp. has announced the completion of a previously announced Series by its majority-owned subsidiary WELLSTAR Technologies Corp. [1] Company Overview - WELL Health Technologies Corp. is a digital healthcare company focused on improving health outcomes through technology [1] - The company aims to empower healthcare practitioners and their patients globally [1] Subsidiary Information - WELLSTAR Technologies Corp. is a majority-owned subsidiary of WELL Health Technologies Corp. [1] - The completion of the Series indicates progress in WELLSTAR's operational and financial strategies [1]